BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020

Rhea-AI Summary

BIOLASE, a leader in dental lasers, announced that CEO Todd Norbe will participate in a webinar on July 16, 2020, focusing on re-engaging medical practices post-COVID-19. The webinar, hosted by Maxim Group and M-Vest, will address key concerns such as the reopening of medical practices, revenue recovery, and commercialization strategies. BIOLASE's innovative laser systems, supported by significant patented technologies, enhance dental procedures and have been sold in over 80 countries, with 41,200 systems deployed to date.

Positive

• CEO Todd Norbe's participation in a relevant industry webinar may enhance BIOLASE's visibility.
• BIOLASE has sold over 41,200 laser systems in more than 80 countries, indicating strong market acceptance.

Negative

• The ongoing COVID-19 pandemic raises uncertainties about revenue recovery and demand for dental services.

IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a panel discussion on Re-Engaging Medical Practices in an Era of COVID-19, presented by Maxim Group and M-Vest on Thursday. July 16, 2020.

Webinar Details:

• Date and Time: Thursday, July 16, 11:00 a.m. Eastern time (8:00 a.m. Pacific time)
• Topic: As the country slowly begins to re-open, information is imperative. How and when will medical practices re-open, and to what extent? Will pent-up demand recoup some of the lost revenue? What are doctors observing as they re-engage with patients? Does commercialization pick up where it left off? How are companies adjusting their commercialization strategies and practices during this time? What does access to capital look like in a re-opening world? This webinar intends to explore these questions and more, with insights from management, engaging Q&A, and informative panel discussions.
• Webcast: To access the panel discussion, please RSVP HERE

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine.  BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately patented 261 and 52 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-to-present-at-covid-19-webinar-hosted-by-maxim-group-on-july-16-2020-301090386.html

SOURCE BIOLASE, Inc.

FAQ

What is the purpose of BIOLASE's webinar on July 16, 2020?

The webinar aims to discuss re-engaging medical practices in the post-COVID-19 era, exploring critical aspects like reopening strategies and revenue recovery.

Who will represent BIOLASE in the upcoming webinar?

CEO Todd Norbe will represent BIOLASE in the panel discussion during the webinar.

How many laser systems has BIOLASE sold worldwide?

BIOLASE has sold over 41,200 laser systems in more than 80 countries globally.

What topics will be covered during BIOLASE's webinar?

Topics include the reopening of medical practices, the impact of COVID-19 on revenue, and how companies are adjusting their commercialization strategies.